Immunity to Immunotherapy in Cancer: Mechanisms and Limitations explores the intricate interplay between cancer therapy and the immune system, addressing why some patients do not respond to immunotherapy and scientific solutions in development. The book examines molecular strategies of immune evasion within the tumor microenvironment, providing insights into factors like tumor heterogeneity and immune checkpoint mechanisms that contribute to resistance. Highlighting promising approaches such as combination therapies, personalized medicine, and novel immunotherapeutic agents, the book aims to enhance patient outcomes and advance cancer immunotherapy.
Designed as a comprehensive guide for professionals and researchers, this textbook offers an overview of the latest scientific discoveries and practical applications in cancer therapy. It serves as an invaluable resource for scientists, doctors, academicians, and students, presenting a path toward more effective, non-toxic, and customized cancer treatments. This book is essential for anyone interested in the future of cancer therapy.
"synopsis" may belong to another edition of this title.
Experienced Associate Professor in Pharmacology with a demonstrated history of working in national and international organisations. Strong professional skilled in Pharmaceutical Research, Molecular Biology, Inflammation, and cardiovascular and metabolic diseases.
Dr. Deepa Mandlik is an Associate Professor at Bharati Vidyapeeth (Deemed to be University) Poona College of Pharmacy, Pune. She brings extensive teaching and research experience across her career and has demonstrated outstanding academic achievement in her early training. She has published extensively in reputable national and international journals and has authored several pharmaceutical books along with multiple international book chapters. A recognized PhD guide, she mentors doctoral researchers and oversees a active cohort of postgraduate students. She is a life member of APTI and a member of CRS-Indian Chapter. Her research interests encompass nanotechnology, targeted drug delivery, quality by design, design of experiments, and optimization techniques, reflecting a strong commitment to innovation in pharmaceutical science. Dr. Mandlik is known for integrating rigorous scientific inquiry with teaching and mentorship to advance the development of the next generation of pharmaceutical researchers.
Immunity to Immunotherapy in Cancer: Mechanisms and Limitations explores the intricate interplay between cancer therapy and the immune system, addressing why some patients do not respond to immunotherapy and the scientific solutions in development. The book examines molecular strategies of immune evasion within the tumour microenvironment, providing insights into factors like tumour heterogeneity and immune checkpoint mechanisms that contribute to resistance. Highlighting promising approaches such as combination therapies, personalized medicine, and novel immunotherapeutic agents, it aims to enhance patient outcomes and advance cancer immunotherapy. Designed as a comprehensive guide for professionals and researchers, this textbook offers an overview of the latest scientific discoveries and practical applications in cancer therapy. It serves as an invaluable resource for scientists, doctors, academicians, and students, presenting a path toward more effective, non-toxic, and customized cancer treatments. This book is essential for anyone interested in the future of cancer therapy.
"About this title" may belong to another edition of this title.
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. Seller Inventory # 408898825
Quantity: 3 available
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
Paperback. Condition: new. Paperback. Immunity to Immunotherapy in Cancer Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Seller Inventory # 9780443415517
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # IB-9780443415517
Quantity: 4 available
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. Seller Inventory # 26405336790
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 330 pages. 7.52x1.34x9.25 inches. In Stock. Seller Inventory # __044341551X
Quantity: 2 available
Seller: California Books, Miami, FL, U.S.A.
Condition: New. Seller Inventory # I-9780443415517
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Paperback / softback. Condition: New. New copy - Usually dispatched within 4 working days. Seller Inventory # B9780443415517
Quantity: Over 20 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. Seller Inventory # 18405336796
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: New. 2026. paperback. . . . . . Seller Inventory # V9780443415517
Quantity: Over 20 available
Seller: moluna, Greven, Germany
Condition: New. Provides an in-depth examination of the molecular strategies of immune evasion and the tumor microenvironment, offering critical insights into why some patients do not respond to immunotherapyBridges the gap between current research and pra. Seller Inventory # 2769883102